[HTML][HTML] Opportunities and Challenges in functional genomics research in osteoporosis: report from a Workshop Held by the Causes Working Group of the …
The discovery that sclerostin is the defective protein underlying the rare heritable bone mass
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
Opportunities and Challenges in Functional Genomics Research in Osteoporosis: Report From a Workshop Held by the Causes Working Group of the Osteoporosis …
JH Tobias, EL Duncan, E Kague… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
The discovery that sclerostin is the defective protein underlying the rare heritable bone mass
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
[引用][C] Opportunities and challenges in functional genomics research in osteoporosis: report From a workshop held by the Causes Working Group of the Osteoporosis …
JH Tobias, EL Duncan, E Kague… - Frontiers in …, 2021 - espace.library.uq.edu.au
The discovery that sclerostin is the defective protein underlying the rare heritable bone mass
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
Opportunities and Challenges in Functional Genomics Research in Osteoporosis: Report From a Workshop Held by the Causes Working Group of the Osteoporosis …
JH Tobias, EL Duncan, E Kague… - Frontiers in …, 2020 - europepmc.org
The discovery that sclerostin is the defective protein underlying the rare heritable bone mass
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
[PDF][PDF] Opportunities and Challenges in Functional Genomics Research in Osteoporosis: Report From a Workshop Held by the Causes Working Group of the …
JH Tobias, EL Duncan, E Kague… - Front. Endocrinol. 11 …, 2021 - pure.eur.nl
PERSPECTIVE published: 15 February 2021 doi: 10.3389/fendo. 2020.630875 databases
provide information about potential molecular mediators such as mRNA expression, protein …
provide information about potential molecular mediators such as mRNA expression, protein …
Opportunities and challenges in functional genomics research in osteoporosis: report from a workshop held by the Causes Working Group of the Osteoporosis and …
JH Tobias, EL Duncan, E Kague… - Frontiers in …, 2020 - ora.ox.ac.uk
The discovery that sclerostin is the defective protein underlying the rare heritable bone mass
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
Opportunities and Challenges in Functional Genomics Research in Osteoporosis: Report From a Workshop Held by the Causes Working Group of the Osteoporosis …
JH Tobias, EL Duncan, E Kague… - Recent Advances in …, 2021 - books.google.com
Tobias et al. Functional Genomics Research in Osteoporosis databases provide information
about potential molecular mediators such as mRNA expression, protein expression, and …
about potential molecular mediators such as mRNA expression, protein expression, and …
Opportunities and Challenges in Functional Genomics Research in Osteoporosis: Report From a Workshop Held by the Causes Working Group of the Osteoporosis …
JH Tobias, EL Duncan, E Kague, CL Hammond… - 2021 - repository.cam.ac.uk
The discovery that sclerostin is the defective protein underlying the rare heritable bone mass
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
Opportunities and Challenges in Functional Genomics Research in Osteoporosis: Report From a Workshop Held by the Causes Working Group of the Osteoporosis …
JH Tobias, EL Duncan, E Kague… - Frontiers in …, 2021 - research-information.bris.ac.uk
The discovery that sclerostin is the defective protein underlying the rare heritable bone mass
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
[HTML][HTML] Opportunities and Challenges in Functional Genomics Research in Osteoporosis: Report From a Workshop Held by the Causes Working Group of the …
JH Tobias, EL Duncan, E Kague… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
The discovery that sclerostin is the defective protein underlying the rare heritable bone mass
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …
disorder, sclerosteosis, ultimately led to development of anti-sclerostin antibodies as a new …